Faculty

Institution

Unit

Venue

Meghan Ghiglieri

Research Technician

Northeastern University

Affiliations

College of Science

Biology

Meghan Ghiglieri is currently serving as a Biology Research Technician at Northeastern University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Meghan Ghiglieri

Northeastern University

Research Technician

You can click a keyword to filter the displayed items

pharmacology microbiology clinical microbiology medicine infectious diseases antibiotics veterinary medicine mycobacterium tuberculosis chemical biology enzyme inhibition medicinal research gram-negative pathogens dna gyrase inhibitor microbial pathogenesis molecular medicine gastroenterology virology tuberculosis biological chemistry applied microbiology molecular regulation rna biology cancer biology bacteriology antibacterial agents computational identification gram-negative bacteria lyme disease selective antibiotic decrease abundance cranberry extracts novel antimicrobials uncultured bacteria author correction

Notable Scholarly Works

Notable Federal Grants

Collaborators

Author Correction: Evybactin is a Dna Gyrase Inhibitor That Selectively Kills Mycobacterium Tuberculosis. Nature Chemical Biology (2024)

Yu ImaiGlenn HaukJeffrey QuigleyLibang LiangSangkeun SonMeghan GhiglieriMichael F. GatesMadeleine MorrissetteNegar ShahsavariSamantha NilesDonna BaldisseriChandrashekhar HonraoXiaoyu MaJason J. GuoJames M. BergerKim Lewis

tuberculosisdna gyrase inhibitorenzyme inhibitiontherapeutic targetschemical biologyantibacterial agentsmycobacterium tuberculosismedicinal researchinfectious diseasesbiochemistry

Computational Identification of a Systemic Antibiotic for Gram-Negative Bacteria. Nature Microbiology (2022)

Ryan D. MillerAkira IinishiSeyed Majed ModaresiByung-Kuk YooThomas D. CurtisPatrick J. LariviereLibang LiangSangkeun SonSamantha NicolauRachel BargabosMadeleine MorrissetteMichael F. GatesNorman PittRoman P. JakobParthasarathi RathTimm MaierAndrey G. MalyutinJens T. KaiserSamantha NilesBlake KaravasMeghan GhiglieriSarah E. J. BowmanDouglas C. ReesSebastian HillerKim Lewis

clinical microbiologyveterinary medicinecomputational identificationmicrobiologygram-negative bacteria

Evybactin is a Dna Gyrase Inhibitor That Selectively Kills Mycobacterium Tuberculosis. Nature Chemical Biology (2022)

dna gyrase inhibitorenzyme inhibitionpharmacologymicrobial pathogenesisclinical microbiologyveterinary medicinemolecular regulationchemical biologymycobacterium tuberculosismolecular biologybiological chemistrymedicinal researchrna biologycancer biologymicrobiologymolecular medicine

A Selective Antibiotic for Lyme Disease. Cell (2021)

Nadja LeimerXiaoqian WuYu ImaiMadeleine MorrissetteNorman PittQuentin Favre-GodalAkira IinishiSamta JainMariaelena CaboniInga V LeusVincent BonifaySamantha NilesRachel BargabosMeghan GhiglieriRachel CorsettiMegan KrumpochGabriel FoxSangkeun SonDorota KlepackiYury S PolikanovCecily A FreliechJulie E McCarthyDiane G EdmondsonSteven J NorrisAnthony D'OnofrioLinden T HuHelen I ZgurskayaKim Lewis

medicinepharmacologyantibioticslyme diseaseinfectious diseasesselective antibiotic

Author Correction: A New Antibiotic Selectively Kills Gram-Negative Pathogens. Nature (2020)

Yu ImaiKirsten J. MeyerAkira IinishiQuentin Favre-GodalRobert GreenSylvie ManuseMariaelena CaboniMiho MoriSamantha NilesMeghan GhiglieriChandrashekhar HonraoXiaoyu MaJason J. GuoAlexandros MakriyannisLuis Linares-OtoyaNils BöhringerZerlina G. WuisanHundeep KaurRunrun WuAndré MateusAthanasios TypasMikhail M. SavitskiJosh L. EspinozaAubrie O’RourkeKaren E. NelsonSebastian HillerNicholas NoinajTill F. SchäberleAnthony D’OnofrioKim Lewis

medicinepharmacologygram-negative pathogensclinical microbiologygeneticsantibioticsvirologyauthor correction

Novel Antimicrobials From Uncultured Bacteria Acting Against Mycobacterium Tuberculosis. mBio (2020)

Jeffrey QuigleyAaron PeoplesAsel SarybaevaDallas HughesMeghan GhiglieriCatherine AchornAlysha DesrosiersCintia FelixLibang LiangStephanie MalveiraWilliam MillettAnthony NittiBaldwin TranAshley ZulloClemens AnklinAmy SpoeringLosee Lucy LingKim Lewis

pharmacologynovel antimicrobialsbacteriologyepidemiologyclinical microbiologyveterinary medicineapplied microbiologymycobacterium tuberculosisuncultured bacteriamicrobiology

A New Antibiotic Selectively Kills Gram-Negative Pathogens. Nature (2019)

medicinepharmacologygram-negative pathogensantibioticsinfectious diseases

Cranberry Extracts Promote Growth of Bacteroidaceae and Decrease Abundance of Enterobacteriaceae in a Human Gut Simulator Model. PLoS ONE (2019)

Kathleen O’ConnorMadeleine MorrissettePhilip StrandwitzMeghan GhiglieriMariaelena CaboniHaiyan LiuChristina KhooAnthony D’OnofrioKim Lewis

gastroenterologydecrease abundancemicrobiologycranberry extracts

1
10 / page

Meghan Ghiglieri

Research Technician

Northeastern University

Affiliations

College of Science

Biology

Meghan Ghiglieri is currently serving as a Biology Research Technician at Northeastern University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Meghan Ghiglieri

Northeastern University

Research Technician

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Author Correction: Evybactin is a Dna Gyrase Inhibitor That Selectively Kills Mycobacterium Tuberculosis. Nature Chemical Biology (2024)

tuberculosisdna gyrase inhibitorenzyme inhibitiontherapeutic targetschemical biologyantibacterial agentsmycobacterium tuberculosismedicinal researchinfectious diseasesbiochemistry

Computational Identification of a Systemic Antibiotic for Gram-Negative Bacteria. Nature Microbiology (2022)

clinical microbiologyveterinary medicinecomputational identificationmicrobiologygram-negative bacteria

Evybactin is a Dna Gyrase Inhibitor That Selectively Kills Mycobacterium Tuberculosis. Nature Chemical Biology (2022)

A Selective Antibiotic for Lyme Disease. Cell (2021)

medicinepharmacologyantibioticslyme diseaseinfectious diseasesselective antibiotic

Author Correction: A New Antibiotic Selectively Kills Gram-Negative Pathogens. Nature (2020)

medicinepharmacologygram-negative pathogensclinical microbiologygeneticsantibioticsvirologyauthor correction

Novel Antimicrobials From Uncultured Bacteria Acting Against Mycobacterium Tuberculosis. mBio (2020)

pharmacologynovel antimicrobialsbacteriologyepidemiologyclinical microbiologyveterinary medicineapplied microbiologymycobacterium tuberculosisuncultured bacteriamicrobiology

A New Antibiotic Selectively Kills Gram-Negative Pathogens. Nature (2019)

medicinepharmacologygram-negative pathogensantibioticsinfectious diseases

Cranberry Extracts Promote Growth of Bacteroidaceae and Decrease Abundance of Enterobacteriaceae in a Human Gut Simulator Model. PLoS ONE (2019)

Kathleen O’ConnorMadeleine MorrissettePhilip StrandwitzMeghan GhiglieriMariaelena CaboniHaiyan LiuChristina KhooAnthony D’OnofrioKim Lewis

gastroenterologydecrease abundancemicrobiologycranberry extracts

1
10 / page

Similar Faculty Members

Yftah Tal-Gan

Institution

University of Nevada, Reno

peptide

biochemistry

Sergei Vakulenko

Institution

University of Notre Dame

pharmacology

clinical microbiology

Mayland Chang

Institution

University of Notre Dame

pathology

cancer cell

Nicole S. Sampson

Institution

Stony Brook University

metabolic pathway analysis

metabolomics

Kim Lewis

Institution

Northeastern University

microbiology

pharmacology

Nicholas Noinaj

Institution

Purdue University

protein modeling

structural bioinformatics

Oleg Tsodikov

Institution

University of Kentucky

molecular biology

structural biology

Harvey Rubin

Institution

University of Pennsylvania

microbial pathogenesis

proteome research

Brian Bothner

Institution

Montana State University

molecular footprints

molecular biology

Luiz Bermudez

Institution

Oregon State University

infectious diseases

host-microbe interaction

Similar Faculty Members

Yftah Tal-Gan

Institution

University of Nevada, Reno

peptide

biochemistry

Sergei Vakulenko

Institution

University of Notre Dame

pharmacology

clinical microbiology

Mayland Chang

Institution

University of Notre Dame

pathology

cancer cell

Nicole S. Sampson

Institution

Stony Brook University

metabolic pathway analysis

metabolomics

Kim Lewis

Institution

Northeastern University

microbiology

pharmacology

Nicholas Noinaj

Institution

Purdue University

protein modeling

structural bioinformatics

Oleg Tsodikov

Institution

University of Kentucky

molecular biology

structural biology

Harvey Rubin

Institution

University of Pennsylvania

microbial pathogenesis

proteome research

Brian Bothner

Institution

Montana State University

molecular footprints

molecular biology

Luiz Bermudez

Institution

Oregon State University

infectious diseases

host-microbe interaction